Annals of Neurology

Director, Rocky Mountain MS Center at the University of Colorado

John R. Corboy, M.D. grew up outside Chicago, Illinois.  He did undergraduate, medical school and Neurology training at the University of Pennsylvania and Neurovirology fellowship at the Johns Hopkins University.  He is Professor, Executive Vice-Chair and the inaugural holder of the Charles Elliot Morris Endowed Chair, all in the Department of Neurology at the University of Colorado School of Medicine. In 1997, he founded the University of Colorado Multiple Sclerosis Center, which morphed into the Rocky Mountain Multiple Sclerosis Center (RMMSC) at the University of Colorado in 2008. He is Director of the academic group and of the RMMSC Tissue Bank. He also is Medical Director of the RMMSC, a separate, private, non-profit advocacy organization for MS patients. His main areas of interest are clinical therapeutics in MS, and he continues to maintain an active clinical practice. He is the primary author the DISCOntinuation of disease modifying therapies in MS (DISCOMS) study, the first ever randomized, controlled discontinuation trial in MS patients, funded by PCORI and the NMSS. He is a fellow of the American Academy of Neurology (AAN) and is an elected member of the American Neurological Association and AOA, the medical school honor society.  He has been an active committee member for the AAN since 1998, and is presently on its Science Committee. He is the founding Editor of Neurology: Clinical Practice, and presently Associate Editor for MS and Neuroimmunology at the Annals of Neurology. For fun, he plays golf and ice hockey, snow skis, and hikes and travels with his wife, Alix, and their four children in beautiful Colorado and the mountain west, as well as internationally.